• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 X FILTER SYSTEM - JUGULAR; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 X FILTER SYSTEM - JUGULAR; VENA CAVA FILTER Back to Search Results
Catalog Number RF400J
Device Problems Malposition of Device (2616); Patient-Device Incompatibility (2682); Material Deformation (2976)
Patient Problem Abdominal Pain (1685)
Event Date 10/27/2016
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiry date: 01/2013).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with left lower extremity deep vein thrombosis and unexplained renal failure.Around six years and six months post filter deployment, a computed tomography (ct) abdomen and pelvis without oral or intravenous contrast revealed that the filter tilted, filter strut twisted and struts perforated.The device has not been removed and there were no reported attempts made to retrieve the filter.The patient reportedly experienced abdominal pain; however, the current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately, five years eight months of post-deployment, the patient experienced chest pain and shortness of breath.On the same day, a computed tomography (ct) chest with intravenous contrast showed that there was no evidence of pulmonary embolus.Around ten months and sixteen days later, the patient experienced acute onset of right flank pain and right upper quadrant abdominal pain.On the same day, a computed tomography (ct) abdomen and pelvis without oral or intravenous contrast showed that there was an infrarenal inferior vena cava filter, noted to be in an abnormal but stable position.Several legs of the filter were projected beyond the wall of the cava.This was not an uncommon occurrence.However, one of the legs projected against or minimally into the aorta.Additional leg projected posterior to the aorta, against the posterior wall.There was no evidence for retroperitoneal hemorrhage.Around, eleven months and twenty-one days later, a computed tomography (ct) abdomen and pelvis without oral or intravenous contrast showed that there was an infrarenal inferior vena cava filter.The apex pointed cranially and was tilted, abutted the right lateral inferior vena cava wall.The struts were intact and all the struts were seen pierced through the inferior vena cava walls.A single strut was significantly twisted and appeared to be pierced through the wall of the abdominal aorta superiorly.Therefore, the investigation is confirmed for the material deformation, perforation of the inferior vena cava (ivc) and filter tilt.The definitive root cause could not be determined based upon available information.Labeling review: the review of the instructions for use, indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H10: d4 (expiry date: 01/2013), g4.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with left lower extremity deep vein thrombosis and unexplained renal failure.Around six years and six months post filter deployment, a computed tomography (ct) abdomen and pelvis without oral or intravenous contrast revealed that the filter tilted, filter strut twisted and struts perforated.The device has not been removed and there were no reported attempts made to retrieve the filter.The patient reportedly experienced abdominal pain; however, the current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 X FILTER SYSTEM - JUGULAR
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key10820950
MDR Text Key215933033
Report Number2020394-2020-20406
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
PMA/PMN Number
K082305
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Type of Report Initial,Followup
Report Date 01/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF400J
Device Lot NumberGFTL2136
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/16/2020
Initial Date FDA Received11/10/2020
Supplement Dates Manufacturer Received01/18/2021
Supplement Dates FDA Received02/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PEPCID AND CARAFATE; PEPCID AND CARAFATE
Patient Outcome(s) Other;
Patient Age57 YR
Patient Weight118
-
-